Arbutus Biopharma
ABUS
#6131
Rank
HK$7.17 B
Marketcap
HK$37.30
Share price
1.70%
Change (1 day)
46.72%
Change (1 year)

Market capitalization of Arbutus Biopharma (ABUS)

Market cap: HK$7.17 Billion

As of January 2026 Arbutus Biopharma has a market cap of HK$7.17 Billion. This makes Arbutus Biopharma the world's 6131th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Arbutus Biopharma from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$7.17 B0.3%
2025HK$7.15 B51.47%
2024HK$4.72 B44.22%
2023HK$3.27 B14.95%
2022HK$2.84 B-35.75%
2021HK$4.43 B89.73%
2020HK$2.33 B66.6%
2019HK$1.40 B-18.22%
2018HK$1.71 B-21.05%
2017HK$2.17 B108.5%
2016HK$1.04 B-44.64%
2015HK$1.88 B-28.62%
2014HK$2.63 B123.97%
2013HK$1.17 B114.05%
2012HK$0.54 B288.58%
2011HK$0.14 B-62.57%
2010HK$0.37 B2.54%
2009HK$0.36 B224.37%
2008HK$0.11 B-58.22%
2007HK$0.27 B

End of Day market cap according to different sources

On Jan 6th, 2026 the market cap of Arbutus Biopharma was reported to be:

HK$7.17 Billion
by Nasdaq info icon info icon
HK$7.17 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NRC Health
NRC
HK$3.46 B-51.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
HK$0.14 B-98.02% Bahamas